e-Therapeutics is a systems biology drug discovery company. We are industrialising discovery using computers to predict the effects of intervention on proteins in cells. New drugs are identified systematically and very quickly.
e-Therapeutics uses these capabilities to:
- search for new drugs across several therapeutic areas
- search for new clinical uses for existing drugs
- identify the probability of drug-drug interactions and toxicity
The company’s current portfolio is in anti-infectives, cancer, central nervous system and asthma.
e-Therapeutics also provides consultancy services to pharmaceutical and biotechnology companies analysing drug compounds for indication, efficacy and toxicity.